Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **subcortical reward system pathways** refer not to a single molecule or receptor but rather to an interconnected network of brain regions and neural circuits that mediate responses to rewarding stimuli. The most prominent component is the **mesolimbic dopamine pathway**, which originates in the ventral tegmental area (VTA) and projects primarily to the nucleus accumbens (ventral striatum), but also involves other subcortical structures such as the amygdala, hippocampus, hypothalamus, thalamus, dorsal raphe nucleus, locus coeruleus, globus pallidus, ventral pallidum, substantia nigra pars compacta/reticulata—and cortical areas including prefrontal cortex and anterior cingulate cortex[1][2][5]. These circuits regulate motivation ("wanting"), reinforcement learning ("learning from rewards"), emotional salience ("importance" assigned to cues), executive function over behavior selection ("choosing actions based on expected outcomes"), memory formation about rewarding experiences—and are implicated in addiction as well as several neuropsychiatric conditions[1][2][3]. Because "subcortical reward system pathways" is not a discrete molecular entity but rather an anatomical/functional brain circuit composed of many interacting parts, it is not considered a therapeutic target per se. Instead, individual molecules within these networks—such as dopamine D2 receptors—are targeted by various pharmacological agents. **Note:** This entry does *not* correspond to a canonical drug target such as an enzyme or receptor. It describes an integrated functional/anatomical brain circuit composed of many interacting parts. For structured data purposes it should be flagged as incorrect if only molecular targets are desired.[1][2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Subcortical reward system pathway.